Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has completed its acquisition of Bentley Pharmaceuticals, Inc. (NYSE: BNT), which will operate in Spain under the Teva name.

Bentley Pharmaceuticals, Inc. (NYSE: BNT) ("Bentley" or the "Company") announced today that its stockholders have approved the Agreement and Plan of Merger, dated as of March 31, 2008, by and among the Company, Teva Pharmaceutical Industries Ltd.

CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) completed its previously announced taxable spin-off from Bentley Pharmaceuticals, Inc. (NYSE: BNT) yesterday at 11:59 p.m.

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) and Bentley Pharmaceuticals, Inc. (NYSE: BNT) announced today that they have entered into a definitive agreement under which Teva will acquire Bentley.

Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, today announced that management will host a conference call to discuss fourth-quarter and year-end 2007 financial results on Thursday, March 13, 2008, at 10:00 a.m. (ET).